Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-20

FDA Approved: TISSUEBLUE — Original Application (D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.)

View source ↗

Summary

FDA approved TissueBlue (Brilliant Blue G) from D.O.R.C. for use as a staining dye in ophthalmic surgery to facilitate capsulorhexis during cataract procedures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TISSUEBLUE (Brilliant Blue G)

Snippet

ORIG AP for TISSUEBLUE (BRILLIANT BLUE G)